Search Results - "Murakami, Jurika"
-
1
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
Published in EClinicalMedicine (01-02-2021)“…To develop an effective vaccine against a novel viral pathogen, it is important to understand the longitudinal antibody responses against its first infection…”
Get full text
Journal Article -
2
Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model
Published in Viruses (30-03-2022)“…Low pathogenic H9N2 avian influenza viruses have spread in wild birds and poultry worldwide. Recently, the number of human cases of H9N2 virus infection has…”
Get full text
Journal Article -
3
Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan
Published in Internal Medicine (01-06-2022)“…Objective Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally. Although the…”
Get full text
Journal Article -
4
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022
Published in Emerging infectious diseases (01-11-2022)“…Japan has reported a relatively small number of COVID-19 cases. Because not all infected persons receive diagnostic tests for COVID-19, the reported number…”
Get full text
Journal Article -
5
Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan
Published in One health (01-12-2023)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to circulate in humans since its emergence in 2019. While infection in humans…”
Get full text
Journal Article -
6
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
Published in iScience (21-07-2023)“…SARS-CoV-2 has gradually acquired amino acid substitutions in its S protein that reduce the potency of neutralizing antibodies, leading to decreased vaccine…”
Get full text
Journal Article -
7
Baloxavir Marboxil Treatment of Nude Mice Infected With Influenza A Virus
Published in The Journal of infectious diseases (27-04-2020)“…Abstract Background Immunocompromised patients infected with influenza virus require prolonged treatment with neuraminidase inhibitors, because these patients…”
Get full text
Journal Article -
8
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Published in Nature (London) (07-07-2022)“…The recent emergence of SARS-CoV-2 Omicron (B.1.1.529 lineage) variants possessing numerous mutations has raised concerns of decreased effectiveness of current…”
Get full text
Journal Article -
9
Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets
Published in Nature microbiology (01-01-2020)“…Here we report the isolation of the influenza A/H1N1 2009 pandemic (A/H1N1pdm) and A/H3N2 viruses carrying an I38T mutation in the polymerase acidic protein—a…”
Get full text
Journal Article -
10
Age-related immune-modulating properties of seminal fluid that control the severity of asthma are gender specific
Published in Aging (Albany, NY.) (24-01-2019)“…Reproductive organs play a pivotal role in asthma development and progression, especially in women. Endocrine environment changes associated with the menstrual…”
Get full text
Journal Article -
11
Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan
Published in Internal Medicine (2022)“…Objective Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally. Although the…”
Get full text
Journal Article